Jaffetilchin Investment Partners »

Halozyme Therapeutics shares owned by Jaffetilchin Investment Partners

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Jaffetilchin Investment Partners from 13F filings

Historical chart of Jaffetilchin Investment Partners investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Jaffetilchin Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Jaffetilchin Investment Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $397k 6.1k 64.63
2024-09-30 $5.7k 100 57.24

More positions owned by Jaffetilchin Investment Partners

Ishares Core S&p Total U S Stock Market Etf Etf (ITOT)
Apple Stock (AAPL)
Schwab U S Large-cap Etf Etf (SCHX)
Vanguard Total Stock Market Etf Etf (VTI)
Nvidia Corporation Stock (NVDA)
Vanguard Large-cap Etf Etf (VV)
Ft Vest Us Equity Deep Buffer Etf - January Etf (DJAN)
Invesco Qqq Trust Series I Etf (QQQ)
Fidelity Total Bond Etf Etf (FBND)
Schwab U S Broad Market Etf Etf (SCHB)
Tesla Stock (TSLA)
State Street Spdr Portfolio S&p 1500 Composite Stock Market Etf Etf (SPTM)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Microsoft Corp Stock (MSFT)
Amazon Stock (AMZN)

View all positions for Jaffetilchin Investment Partners

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Invesco
Bank of America Corporation
Robeco Investment Management
Morgan Stanley
William Blair Investment Management
Geode Capital Management
Snyder Capital Management
Dimensional Fund Advisors
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co

View all funds holding Halozyme Therapeutics